Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy

PURPOSE: Activating mutation of the KRAS oncogene is an established negative predictor for anti-epidermal growth factor receptor (anti-EGFR) therapies in metastatic colorectal cancer (CRC). However, KRAS mutation as a prognostic factor of survival outcome remains controversial in CRC, independent of...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Kim, Seung Tae, Park, Kyong Hwa, Kim, Jun Suk, Shin, Sang Won, Kim, Yeul Hong
Formáid: Artigo
Teanga:Inglês
Foilsithe: Korean Cancer Association 2013
Ábhair:
Original Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3629364/
https://ncbi.nlm.nih.gov/pubmed/23613671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2013.45.1.55
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla